NEW YORK (GenomeWeb News) – Evotec has agreed to provide Biogen Idec with high-throughput screening and assay development services for a particular target, Evotec said today.

Evotec said that it will use its protein production, assay development, and screening technologies to identify drug candidates for Biogen Idec. The agreement also includes an option to cover further targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.